Home | Business News | Browse by Publication | P | PR Newswire

TKT Gains Early Access to Dynepo(TM) Oncology Data.

Publication: PR Newswire
Publication Date: 13-SEP-04 		Format: Online
Delivery: Immediate Online Access

Article Excerpt
Transkaryotic Therapies, Inc. today announced that Sanofi-Aventis SA granted the company a license to clinical trial results from a controlled Phase III clinical trial evaluating Dynepo(TM) (epoetin delta), its Gene-Activated(R) erythropoietin product, for the treatment of anemia in cancer patients treated with chemotherapy. TKT expects that top-line results of the clinical trial will be available in the first half of 2005. If the data are positive, TKT intends to file an amendment to the European Dynepo product license in order to expand its approved indication to include anemia associated with cancer chemotherapy. In a March 2004 agreement, TKT regained marketing rights to Dynepo outside the United States but would only receive data from the cancer chemotherapy study upon completion of U.S. patent litigation. Dynepo was approved in the European Union in March 2002 for the treatment of anemia associated with renal disease in dialysis and pre-dialysis patients.

"We continue to anticipate the...

Read the FULL article now - Try Goliath Business News - FREE!   
You can view this article PLUS...

  • Over 5 million business articles
  • Hundreds of the most trusted magazines, newswires, and journals (see list)
  • Premium business information that is timely and relevant
  • Unlimited Access

Now for a Limited Time, try Goliath Business News - Free for 3 Days!
Tell Me More   Terms and Conditions

Get Goliath Business News for 1 year - Just $99 (Save 65%)
Tell Me More   Terms and Conditions

Already a subscriber? Log in to view full article



More articles from PR Newswire
Mykrolis Corporation to Present at the Banc of America Securities 34th..., September 13, 2004
Color Kinetics Demonstrates Breakthrough Power Solution and Innovative..., September 13, 2004
FDA Approves iCAD's New Second Look(R) Digital Computer Aided Detectio..., September 13, 2004
Barnett Releases State Clinical Trial Requirements Reference Guide., September 13, 2004
Thermo Electron Acquires InnaPhase Corporation., September 13, 2004

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.